Send SMSSend SMS Send InquirySend Inquiry
Amorolfine 0.25 % W/W Cream

Amorolfine 0.25 % W/W Cream

Product Details:

  • Drug Type General Medicines
  • Ingredients AMOROLFINE
  • Physical Form Other
  • Function Other
  • Recommended For MEDICINE
  • Dosage 20
  • Dosage Guidelines 1
  • Supply Ability : 100 Pack Per Day
  • Click to view more
X

Price And Quantity

  • 100 Pack
  • 250 INR

Product Specifications

  • Other
  • Other
  • General Medicines
  • 25
  • 1
  • Suitable For All
  • MEDICINE
  • AMOROLFINE
  • 20
  • 1 Unit

Trade Information

  • ST
  • Cheque
  • 100 Pack Per Day
  • 1 Months
  • Within a certain price range free samples are available
  • LAMITUBE
  • Africa, Middle East, Asia
  • All India
  • FDA

Product Description



NIKSANHEALTHCARE Is State Of Art, FDCA, ISO 9001: 2015, WHO, GMP, GLP Certified FacilityTo Develop And Manufacture Highly Quality Pharmaceutical Finished Formulations.Niksan Healthcare Is Manufacturer, Exporter, Suppliers, Distributor, Trader AndDealer Of High Quality Pharmaceutical Tablets, Capsules, Gels, Creams,Ointments, Syrups, Suspensions, Injection, Pellets, Nasal Sprays, Lotions,Shampoo, Face wash, Hand wash, Hand Sanitizer, Veterinary Medicines, Dry PowderIn Pouch Pack, Surgical And Medicated Soaps.

NIKSAN HEALTHCARE Is An Excellent Combination Of World ClassState Of Art Manufacturing, F & D, R & D, Quality Control, QualityAssurance, Marketing And In Depth Management Expertise. We Are Manufacturer,Exporter, Suppliers, Distributor, Trader and Dealer of High QualityPharmaceutical Finished Formulations. The Values Inspiring All Our Work AreExcellence And Highly Effectiveness.

NIKSAN HEALTHCARE Works to Improve Patients Quality Of LifeAnd To Respond To Their Potential Needs. We Carefully Select Our Partners InOrder To Maintain Highest Standards In Technology, Competence, Reliability AndCompetitiveness.

NIKSANHEALTHCARE is well known pharmaceutical manufacturer in a field ofPharmaceutical formulation for AMOROLFINE 0.25% CREAM. We are manufacturer, exporter andsupplier of a huge stock of AMOROLFINE 0.25% CREAM in Ankleshwar, Gujarat, India. Ouroffered AMOROLFINE 0.25% CREAM is widely appreciated by our clientswhich are situated all-round the nation. We offer AMOROLFINE 0.25%CREAMat most affordable prices.

NIKSANHEALTHCARE is manufacturing and exporting AMOROLFINE 0.25%CREAM from last manyyear in country like New Zealand, Jordan, Belgium, United Kingdom, Australia,Italy, Ireland, Hong Kong, Morocco,, Portugal, France, South Africa,Philippines, Malaysia, Singapore, Israel, Greece, Saudi Arabia, Egypt, Taiwan,Netherlands, South Korea, Switzerland, Algeria, Pakistan, Canada, Vietnam,United States, Germany, Brazil and many other countries.

NIKSAN HEALTHCARE is providing thisformulation to many Indian stats like Andhra Pradesh, Assam, Arunachal Pradesh, Bihar, Goa, Gujarat, Jammu andKashmir, Jharkhand, West Bengal, Karnataka, Kerala, Madhya Pradesh, Maharashtra,Manipur, Meghalaya, Mizoram, Nagaland, Orissa, Punjab, Rajasthan, Sikkim, TamilNadu, Tripura, Uttaranchal, Uttar Pradesh, Haryana, Himachal Pradesh, andChhattisgarh.Thisproduct available in different packaging style flat box, cream jar, squeezetube and collapsible tube packing and also in mono carton box.

AMOROLFINE 0.25%CREAM

Thismedicine contains Amorolfine as an active ingredient.

Amorolfine isan antifungal treatment for fungal infections of the fingernails and toenails.

Apply the naillacquer once each week.

Treatment mayneed 6 to 12 months of treatment.

Amorolfine,is a morpholine antifungal drug that inhibits Δ¹⁴-sterol reductase and cholestenol Δ-isomerase

CommonSide Effects

Burning sensation

Dryness of skin

Scaling

Itching

Erythematic

Weeping

HOWTO USE: apply a small amount of medication to cover the affected areaof skin with a thin, even film and rub in gently. The area may be covered witha gauze dressing or gelatin packing if your doctor has told you to do so.

PHARMACOKINETICS

Properties Amorolfine penetration throughhuman nail follows an exponential relationship between drug concentration andnail layer. In vitro data suggest that soft diseased nails will retain lessdrug than hard compact nails.

PRECAUTIONS:

Beforeusing the medication tell your doctor if you are allergic to medicine. Tellyour doctor if you have any problem like skin problem, eczema etc. Do not takethis medicine if you are having stomach ulcer.

STORAGECONDITIONS: Store incool and dry place, away from direct heat and light. Do not place in bathroomor kitchen. Keep away from the children and pet.

CDSCO APPROVED:

AMOROLFINE CREAM approved in India in 25/11/2003

AVAILABLE BRANDS IN MARKET

AMROTRA(ALLEGIANT PHARMACEUTICALS)

AMROLWIN(CONNOTE HEALTHCARE)

LOCERY(ARIHANT PHARMACEUTICALS)

AMROLSTAR(OAKNET HEALTHCARE)

LIVAFIN(CADILA LTD)

NOTE: Products protected byvalid patents are not offered for sale in countries where the sale of suchproducts constitutes a patent infringement and its liability is at buyer'srisk.

Website:

http://www.niksanhealthcare.com/

https://niksan-healthcare.business.site/

 

B2BSite

Exporterindia-https://www.exportersindia.com/niksan-healthcare/

Tradindia-https://www.tradeindia.com/Seller-25082492-NIKSAN-HEALTHCARE/

Indiamart-https://www.indiamart.com/niksan-healthcare/

 

Follow me

Facebook-https://www.facebook.com/niksan.healthcare

Linkedin-https://www.linkedin.com/in/niksan-healthcare-3749311b7/

Blogspot-https://niksanhealthcare.blogspot.com

Instagram-https://www.instagram.com/niksanhealthcare/?hl=en

Reddit-https://www.reddit.com/user/niksan_healthcare

Skype -Niksanhealthcare       

Tumblr -https://www.tumblr.com/blog/niksan-healthcare

ACKNOWLEDGMENT

We are heartfelt thankful to YOUTUBE and also grateful toGOOGLE

REFERENCES:

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult

 

 

 

 

 


NIKSAN HEALTHCARE

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Back to top